HCPLive Network

Diabetics Have Beer Goggles for a Different Reason

Patients with diabetes who like to have a drink or two were recently given a bit of good news when a study out of Boston University found that moderate drinkers with diabetes were in better health than their heavy- and non-drinking peers. As it turns out, though, the alcohol that's helping to keep these individuals in good health may be contributing to problems with their vision.

A new study published in Diabetic Medicine reveals that among patients with type 2 diabetes, alcohol consumption was associated with an increased risk of deterioration of visual acuity.

Patients with type 2 diabetes are at increased risk to develop complications like cardiovascular disease, renal disease, and retinopathy. Previous studies have suggested that moderate alcohol consumption could reduce the risk of cardiovascular disease and other complications among type 2 diabetes patients.

Researchers led by Joline WJ Beulens, PhD, of the University Medical Center Utrecht, studied over 1,200 type 2 diabetes patients over five and half years and reviewed current and past consumption of wine, spirits, and beer. Moderate alcohol consumption was defined as one to 14 drinks a week and heavy alcohol consumption was defined as more than 14 drinks a week.

Findings reveal that alcohol consumption was associated with a more than 50% increased risk of deterioration of visual acuity over that time but was not related to typical diabetes related eye disease. Deterioration was defined by a decrease of two lines in best vision in either eye.

“Our study is the first to show this association,” said Dr. Beulens. “Lifestyle factors, including alcohol consumption, may alter the risk of visual loss in individuals with diabetes. This is a first observational study and our findings should be replicated.”

Source: Wiley-Blackwell

Further Reading
More patients in the RIDE and RISE trials treated with the VEGF inhibitor showed improvements in vision test scores compared to patients who received placebo.
For individuals with type 2 diabetes, incident cardiovascular outcomes are determined not only by the severity of diabetic retinopathy but also by its progression, according to research published online Dec. 13 in Diabetes Care.
It's a delicate balance that keeps retinal neovascularization under control and vascular endothelial growth factor seems to be the bad guy in the relationship.
Advanced glycation end products may explain why some diabetics live free from eye, kidney, nerve, and cardiovascular complications for more than 5 decades.
Triglycerides, HDL cholesterol, and diabetes (but not higher fasting blood sugar) cut down memory scores, visual working memory, and word fluency.
Most drugs reduce blood sugar similarly, but metformin is consistently associated with fewer side effects and can cost as much as 18 times less.
A blood screen testing for elevations in five amino acids can identify individuals at risk of developing type 2 diabetes a decade prior to symptom onset.
More Reading